Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chel Hun Choi

Showing results (191-200 of 309) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|November 5, 2013
Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 casesAera Yoon, Jeong-Yeol Park, Jin-Young Park, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 27, 2018
The role of appendectomy in patients with mucinous borderline ovarian tumorsTaejong Song, Min Kyu Kim, Yong Wook Jung, et al.
Journal of Clinical Medicine|April 23, 2020
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using <i>cis</i>-eQTL AnalysisJihye Kim, Joon-Yong Chung, Jae Ryoung Hwang, et al.
Cancer Research and Treatment|August 13, 2019
Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)E Sun Paik, Myong Cheol Lim, Moon-Hong Kim, et al.
Gynecologic Oncology|June 7, 2011
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysisYoo-Young Lee, Tae-Joong Kim, Min-Ji Kim, et al.
Gynecologic Oncology|July 6, 2019
Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028)E Sun Paik, Myong Cheol Lim, Moon-Hong Kim, et al.
The Journal of Obstetrics and Gynaecology Research|May 25, 2010
Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapyChel Hun Choi, Sang Yong Song, Heeseok Kang, et al.
Journal of Clinical Medicine|September 16, 2020
The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical CancerJoseph J Noh, Myong Cheol Lim, Moon-Hong Kim, et al.
Obstetrics & Gynecology Science|May 22, 2018
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancerWonkyo Shin, Hye-Joo Lee, Seong J Yang, et al.
Anticancer Research|April 9, 2013
Clinical significance of galectin-7 in epithelial ovarian cancerHa-Jeong Kim, Hye-Kyung Jeon, Jae-Kwan Lee, et al.
Pageof 31

Showing results (191-200 of 309) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|November 5, 2013
Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 casesAera Yoon, Jeong-Yeol Park, Jin-Young Park, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 27, 2018
The role of appendectomy in patients with mucinous borderline ovarian tumorsTaejong Song, Min Kyu Kim, Yong Wook Jung, et al.
Journal of Clinical Medicine|April 23, 2020
Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using <i>cis</i>-eQTL AnalysisJihye Kim, Joon-Yong Chung, Jae Ryoung Hwang, et al.
Cancer Research and Treatment|August 13, 2019
Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)E Sun Paik, Myong Cheol Lim, Moon-Hong Kim, et al.
Gynecologic Oncology|June 7, 2011
Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysisYoo-Young Lee, Tae-Joong Kim, Min-Ji Kim, et al.
Gynecologic Oncology|July 6, 2019
Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028)E Sun Paik, Myong Cheol Lim, Moon-Hong Kim, et al.
The Journal of Obstetrics and Gynaecology Research|May 25, 2010
Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapyChel Hun Choi, Sang Yong Song, Heeseok Kang, et al.
Journal of Clinical Medicine|September 16, 2020
The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical CancerJoseph J Noh, Myong Cheol Lim, Moon-Hong Kim, et al.
Obstetrics & Gynecology Science|May 22, 2018
Retrospective study of combination chemotherapy with etoposide and ifosfamide in patients with heavily pretreated recurrent or persistent epithelial ovarian cancerWonkyo Shin, Hye-Joo Lee, Seong J Yang, et al.
Anticancer Research|April 9, 2013
Clinical significance of galectin-7 in epithelial ovarian cancerHa-Jeong Kim, Hye-Kyung Jeon, Jae-Kwan Lee, et al.
Pageof 31